Skip to main content
. 2017 May 24;8:595. doi: 10.3389/fimmu.2017.00595

Table 1.

Vaccine dosage and study schema.

Group N Vaccine dosagea Vaccine given at months
0 1 2 6 12
A 6 CN54gp140 + GLA-AF + + + +
B 6 CN54gp140 + GLA-AF + + + +

aVaccines: recombinant uncleaved clade C HIV-1 envelope gp140 protein (CN54gp140) administered intramuscularly into the deltoid muscle of the upper arm at a dosage of 100 µg CN54gp140 formulated with 5 µg glucopyranosyl lipid A-aqueous formulation in a total volume of 0.4 ml.